Real-world data analysis of adjuvant capecitabine for triple-negative breast cancer after neoadjuvant chemotherapy
Patients who achieved pCR had better outcomes compared to those who didn't. Among patients who didn't achieve pCR, the addition of capecitabine didn't result in significant improvements in DFS or OS compared to those who didn't receive adjuvant treatment.
Authors
- Javier Pascual (ORCID: https://orcid.org/0000-0003-3874-2782)
- Marcos Iglesias (ORCID: https://orcid.org/0000-0002-7523-5950)
- Amaya López-Pascual (ORCID: https://orcid.org/0000-0001-6091-8225)
- Ester Martín-Villar (ORCID: https://orcid.org/0000-0003-2910-2345)
- Ana Godoy-Ortíz (ORCID: https://orcid.org/0000-0002-5503-6946)
- Emilio Alba (ORCID: https://orcid.org/0000-0002-3364-2603)
- María Emilia Domínguez-Recio (ORCID: https://orcid.org/0000-0001-9015-6559)
- Antonio Rueda‐Domínguez (ORCID: https://orcid.org/0000-0001-5890-0149)
- Bella Pajares (ORCID: https://orcid.org/0000-0002-3276-5169)
- María José Bermejo (ORCID: https://orcid.org/0000-0002-6293-850X)
- F. Carabantes
- Tamara Díaz-Redondo
- Manuel Zalabardo-Aguilar (ORCID: https://orcid.org/0000-0001-8343-1815)
- Nuria Ribelles (ORCID: https://orcid.org/0000-0003-3194-7398)
- Gonzalo Lendínez-Sánchez (ORCID: https://orcid.org/0009-0005-4733-6921)
- Alexandra Cantero (ORCID: https://orcid.org/0000-0001-6431-6432)
- Alfonso Sánchez‐Muñoz
Institutions
- Hospital Regional Universitario de Málaga (ES)
- Hospital Clínico Universitario Virgen de la Victoria (ES)
- Centro de Investigación Biomédica en Red de Cáncer (ES)
- Instituto de Investigación Biomédica de Málaga (ES)
- Universidad de Málaga (ES)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-11-17
- DOI
- https://doi.org/10.3389/fonc.2025.1648272
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00